Study Evaluating the Safety and Efficacy of Intravenous Tigecycline to Treat Hospitalized Japanese Subjects

NCT00575094 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

9

Enrollment

INDUSTRY

Sponsor class

Conditions

Community-Acquired Infections

Interventions

DRUG: tigecycline

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer